Summary
Plasma volume expanders are effective in the restoration of blood volume. All the available plasma volume expanders may rarely induce anaphylactoid reactions, although such reactions are extremely uncommon in shocked patients. The reactions are caused by different mechanisms depending on the solution, and there is little evidence that IgE antibodies are involved. In addition to these reactions, effects on haemostasis and renal function may occur, and the persistence of hydroxyethyl starch in the body has led to concern about its potential role as a carcinogen, although there is no evidence to suggest that this has occurred.
Similar content being viewed by others
References
Adlmann B, Schoning B. Binding of native and denatured collagen to immunoglobulins and cold insoluble globulin (CIG) in serum of patients undergoing orthopaedic surgery. Klinische Wochenschrift 58: 625–629, 1980
Alexander B. Effects of plasma expanders on coagulation and haemostasis: dextran, hydroxyethyl starch, and other macro-molecules revisited; blood colloids and plasma expanders. Progress in Clinical and Biological Research 19: 292–298, 1978
Annest SJ, Scoulli WA, Blumenstock FA, Stratton HH, Newell JC, et al. Increased creatinine clearance following cryoprecipitate infusion in trauma and surgical patients with decreased renal function. Journal of Trauma 20: 726–730, 1980
Bernstein RL, Rosenberg AD, Pada EY, Jaffe FF. A severe reaction to dextran despite hapten inhibition. Anaesthesiology 67: 567–569, 1987
Biro GP. Fluorocarbons in resuscitation of haemorrhage. International Anaesthesiology Clinics 23: 143–168, 1985
Bland JHL, Laver MB, Lowenstein E. Vasodilator effect of commercial 5% plasma protein solutions. Journal of the American Medical Association 224: 1721–1723, 1973
Boon JC, Jesch F, Ring J, Messmer K. Long term intravascular persistence of hydroxyethyl starch (HES) in man. European Surgical Research 8: 497–503, 1976
Claggett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients: results of meta-analysis. Annals of Surgery 208: 227–240, 1988
Coghill TH, Moore EE, Dunn EL, Cohen RG. Coagulation changes after albumin resuscitation. Critical Care Medicine 9: 22–26, 1981
Colman WR. Paradoxical hypotension after volume expansion with protein fractions. New England Journal of Medicine 229: 66–69, 1978
Dahn MS, Lucas CE, Ledgerwood AM, Higgins RF. Negative inotropic effect of albumin resuscitation for shock. Surgery 86: 235–239, 1979
Elliott LA, Legerwood AM, Lucas CM, et al. Role of Fluosol DA 20% in prehospital resuscitation. Critical Care Medicine 17: 166–172, 1989
Engberg A. Effects of dextran 40 on the proximal renal tubule. Acta Chirurgica Scandinavica 142: 172–175, 1976
Fisher MM. Anaphylaxis. Disease a Month 33: 435–479, 1987
Fisher MM. Direct histamine release in anaesthesia and surgery: unanswered questions. Theoretical Surgery 3: 145–147, 1988
Hedin H, Richter W, Ring J. Dextran-induced anaphylactoid reactions in man: role of dextran reactive antibodies. Internal Archives of Allergy and Applied Immunology 52: 145–159, 1976
Hossaini AA, Wasserman JJ, Venart GP. Experimental induction of caprylate dependent albumin antibodies. American Journal of Clinical Pathology 65: 513–516, 1975
Isbister JP, Biggs JC. Reaction to rapid infusion of soluble plasma protein solution during large volume plasma exchange. Anaesthesia and Intensive Care 4: 105–109, 1976
Isbister JP, Fisher MM. Adverse effects of plasma volume expanders. Anaesthesia and Intensive Care 8: 145–151, 1980
Johnson SD, Lucas CE, Gerrick SJ, Ledgerwood AM, Higgins RF. Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery 114: 379–383, 1979
Klein RE, Kogollon G. Erythema multiforme following the infusion of hydroxyethyl starch. Transfusion 68: 166–167, 1984
Kohler H, Kirch W, Horstman HJ. Hydroxyethyl starch-induced macroamylasemia. International Journal of Clinical Pharmacology and Biopharmacy 15: 428–429, 1977
Kovalik SG, Ledgerwood AM, Lucas CE, Higgins RF. The cardiac effect of altered calcium haemostasis after albumin resuscitation. Journal of Trauma 21(4): 275–279, 1981
Kraft D, Hedin H, Richter W, Scheiner O, Rumpold H, et al. Immunoglobulin class and subclass distribution of dextran-reactive antibodies in human reactors and non reactors to clinical dextran. Allergy 37: 481–489, 1982
Lockwood DNJ, Bullen C, Machin SJ. A severe coagulopathy following volume replacement with hydroxyethyl starch in a Jehovah’s Witness. Anaesthesia 43: 391–393, 1988
Lorenz W, Doenicke A, Schoning B, Karges H, Schmal A. Incidence and mechanisms of adverse reactions to polypeptides in man and dog. In Joint WHO/IABS Symposium of the Standardization of Albumin, Plasma Substitutes, and Plasmaphoresis, Geneva 1980, Development Biological Standard 48, S. Karger Basel, pp. 207–234, 1981
Lucas CE, Denis R, Legerwood AM, Grabow D. The effects of hespan on serum and lymphatic albumin, globulin and coagulant protein. Annals of Surgery 207: 416–420, 1988
Messmer K, Ljunstrom K-G, Gruber U-F, Richter W, Hedin H. Prevention of dextran-induced anaphylactoid reactions by hapten inhibition. Lancet 1: 975–977, 1980
Mitsuno T, Ohyanagi H, Naito R. Clinical studies of a perfluorochemical whole blood substitute (Fluosol DA). Annals of Surgery 195: 60–69, 1982
Paull J. A prospective study of dextran-induced anaphylactoid reactions in 5745 patients. Anaesthesia and Intensive Care 15: 163–167, 1987
Rajagopalan PR, Reines HD, Pulliam C, Fitts CT, LeVeen HH. Reversal of acute renal failure using haemodilution with hydroxyethyl starch. Journal of Trauma 23: 795–800, 1983
Raper RF, Fisher MM. Resuscitation in acute haemorrhage. Anaesthesia and Intensive Care 12: 212–216, 1984
Renck H, Ljungstrom K-G, Hedin H, Richter W. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. Acta Chirurgica Scandanavica 149: 355–360, 1983
Ring J. Colloids. Clinics in Anaesthesiology 2: 619–641, 1984
Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1: 466–469, 1977
Ring J, Stephan W, Brendel W. Anaphylactoid reactions to infusion of plasma protein and human serum albumin. Clinical Allergy 9: 89–99, 1979
Schwarz J, Ihle B, Dowling J. Acute renal failure induced by low molecular weight dextran. Australian and New Zealand Journal of Medicine 14: 688–690, 1984
Torda TA, Harrisson GA, McCulloch CH, Wright JS, Stacey R, et al. Circulatory effects of stable plasma protein solution (SPPS). Medical Journal of Australia 1: 798–800, 1973
Tremper KK, Lapin R, Levine E, et al. Haemodynamic and oxygen transport effects of a perfluorochemical blood substitute. Critical Care Medicine 8: 738–741, 1980
Vercellotti G, Hammerschmidt BE, Craddock P. Activation of plasma complement by perfluorocarbon: possible mechanism of adverse pulmonary reactions in treated patients. Blood 59: 1299–1304, 1982
Vervloet D, Senft M, Dugue P, Arnaud A, Charpin J. Anaphylactic reactions to modified gelatins. Journal of Allergy and Clinical Immunology 71: 535–540, 1983
Ziegler HK. Sektionstefund bei Dextranzwischenfall. Medizinische Klinik 73: 1089–1090, 1978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fisher, M.M., Brady, P.W. Adverse Reactions to Plasma Volume Expanders. Drug-Safety 5, 86–93 (1990). https://doi.org/10.2165/00002018-199005020-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199005020-00002